Expect Buzz About Rebyota Fecal Product for C. diff
New Rx Rebyota will be the first FDA-approved fecal microbiota product for preventing C. difficile recurrence in adults.
It seems unappealing, but a fecal transplant can help restore a healthy GI flora...or “microbiota.”
Expect to save fecal transplants for a patient who has 3 or more C. diff episodes despite treatment...or possibly for any case of severe, refractory C. diff when antibiotics don’t work at all.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote